280 related articles for article (PubMed ID: 31065578)
1. Evaluation of iron deposition in brain basal ganglia of patients with Parkinson's disease using quantitative susceptibility mapping.
Shahmaei V; Faeghi F; Mohammdbeigi A; Hashemi H; Ashrafi F
Eur J Radiol Open; 2019; 6():169-174. PubMed ID: 31065578
[TBL] [Abstract][Full Text] [Related]
2. Region-specific disturbed iron distribution in early idiopathic Parkinson's disease measured by quantitative susceptibility mapping.
He N; Ling H; Ding B; Huang J; Zhang Y; Zhang Z; Liu C; Chen K; Yan F
Hum Brain Mapp; 2015 Nov; 36(11):4407-20. PubMed ID: 26249218
[TBL] [Abstract][Full Text] [Related]
3. Iron deposition in Parkinson's disease by quantitative susceptibility mapping.
Chen Q; Chen Y; Zhang Y; Wang F; Yu H; Zhang C; Jiang Z; Luo W
BMC Neurosci; 2019 May; 20(1):23. PubMed ID: 31117957
[TBL] [Abstract][Full Text] [Related]
4. Time-Specific Pattern of Iron Deposition in Different Regions in Parkinson's Disease Measured by Quantitative Susceptibility Mapping.
Fu X; Deng W; Cui X; Zhou X; Song W; Pan M; Chi X; Xu J; Jiang Y; Wang Q; Xu Y
Front Neurol; 2021; 12():631210. PubMed ID: 34421781
[TBL] [Abstract][Full Text] [Related]
5. Extra-basal ganglia iron content and non-motor symptoms in drug-naïve, early Parkinson's disease.
Kim M; Yoo S; Kim D; Cho JW; Kim JS; Ahn JH; Mun JK; Choi I; Lee SK; Youn J
Neurol Sci; 2021 Dec; 42(12):5297-5304. PubMed ID: 33860863
[TBL] [Abstract][Full Text] [Related]
6. Utility of quantitative susceptibility mapping and diffusion kurtosis imaging in the diagnosis of early Parkinson's disease.
Tan S; Hartono S; Welton T; Ann CN; Lim SL; Koh TS; Li H; Setiawan F; Ng S; Chia N; Liu S; Mark Haacke E; King Tan E; Chew Seng Tan L; Ling Chan L
Neuroimage Clin; 2021; 32():102831. PubMed ID: 34619654
[TBL] [Abstract][Full Text] [Related]
7. Quantitative evaluation of brain iron accumulation in different stages of Parkinson's disease.
Li KR; Avecillas-Chasin J; Nguyen TD; Gillen KM; Dimov A; Chang E; Skudin C; Kopell BH; Wang Y; Shtilbans A
J Neuroimaging; 2022 Mar; 32(2):363-371. PubMed ID: 34904328
[TBL] [Abstract][Full Text] [Related]
8. Regionally progressive accumulation of iron in Parkinson's disease as measured by quantitative susceptibility mapping.
Guan X; Xuan M; Gu Q; Huang P; Liu C; Wang N; Xu X; Luo W; Zhang M
NMR Biomed; 2017 Apr; 30(4):. PubMed ID: 26853890
[TBL] [Abstract][Full Text] [Related]
9. Combined Application of Quantitative Susceptibility Mapping and Diffusion Kurtosis Imaging Techniques to Investigate the Effect of Iron Deposition on Microstructural Changes in the Brain in Parkinson's Disease.
Yang L; Cheng Y; Sun Y; Xuan Y; Niu J; Guan J; Rong Y; Jia Y; Zhuang Z; Yan G; Wu R
Front Aging Neurosci; 2022; 14():792778. PubMed ID: 35370619
[TBL] [Abstract][Full Text] [Related]
10. Iron deposition heterogeneity in extrapyramidal system assessed by quantitative susceptibility mapping in Parkinson's disease patients with type 2 diabetes mellitus.
Li W; Gao B; Du W; Jiang Y; Yang J; Hu R; Liu Y; Liu N; Zhang Y; Song Q; Miao Y
Front Aging Neurosci; 2022; 14():975390. PubMed ID: 36177478
[TBL] [Abstract][Full Text] [Related]
11. Histogram Analysis of Quantitative Susceptibility Mapping for the Diagnosis of Parkinson's Disease.
Zhang Y; Yang M; Wang F; Chen Y; Liu R; Zhang Z; Jiang Z
Acad Radiol; 2022 Mar; 29 Suppl 3():S71-S79. PubMed ID: 33189552
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of QSM over R2* in assessment of parkinson's disease - A systematic review.
Saikiran P;
Neurol India; 2020; 68(2):278-281. PubMed ID: 32415005
[TBL] [Abstract][Full Text] [Related]
13. Quantitative Susceptibility Mapping in Parkinson's Disease.
Langkammer C; Pirpamer L; Seiler S; Deistung A; Schweser F; Franthal S; Homayoon N; Katschnig-Winter P; Koegl-Wallner M; Pendl T; Stoegerer EM; Wenzel K; Fazekas F; Ropele S; Reichenbach JR; Schmidt R; Schwingenschuh P
PLoS One; 2016; 11(9):e0162460. PubMed ID: 27598250
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of abnormal iron distribution in specific regions in the brains of patients with Parkinson's disease using quantitative susceptibility mapping and R2
Cheng Q; Huang J; Liang J; Ma M; Zhao Q; Lei X; Shi C; Luo L
Exp Ther Med; 2020 Jun; 19(6):3778-3786. PubMed ID: 32346442
[TBL] [Abstract][Full Text] [Related]
15. Distribution pattern of iron deposition in the basal ganglia of different motor subtypes of Parkinson's disease.
Zhang X; Li L; Qi L; Fu Y; Sun D; Chen S; Xu W; Liu C; Zhou X; He G
Neurosci Lett; 2023 Jun; 807():137249. PubMed ID: 37061026
[TBL] [Abstract][Full Text] [Related]
16. Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping.
An H; Zeng X; Niu T; Li G; Yang J; Zheng L; Zhou W; Liu H; Zhang M; Huang D; Li J
J Neurol Sci; 2018 Mar; 386():46-52. PubMed ID: 29406966
[TBL] [Abstract][Full Text] [Related]
17. Spatiotemporal patterns of brain iron-oxygen metabolism in patients with Parkinson's disease.
Yan S; Lu J; Li Y; Cho J; Zhang S; Zhu W; Wang Y
Eur Radiol; 2024 May; 34(5):3074-3083. PubMed ID: 37853173
[TBL] [Abstract][Full Text] [Related]
18. Investigating Optimal Echo Times for Quantitative Susceptibility Mapping of Basal Ganglia Nuclei in the Healthy Brain.
Fan W; Wang X; Zhang X; Liu M; Meng Q; Chen Z
Curr Med Imaging; 2020; 16(8):991-996. PubMed ID: 33081660
[TBL] [Abstract][Full Text] [Related]
19. Evaluating iron deposition in gray matter nuclei of patients with unilateral middle cerebral artery stenosis using quantitative susceptibility mapping.
Mao H; Dou W; Chen K; Wang X; Wang X; Guo Y; Zhang C
Neuroimage Clin; 2022; 34():103021. PubMed ID: 35500369
[TBL] [Abstract][Full Text] [Related]
20. Iron deposition in subcortical nuclei of Parkinson's disease: A meta-analysis of quantitative iron-sensitive magnetic resonance imaging studies.
Jin J; Su D; Zhang J; Lam JST; Zhou J; Feng T
Chin Med J (Engl); 2024 May; ():. PubMed ID: 38809051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
